XNCR FY 2017 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$861M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$36M-59.2% YoY

Gross Profit

-$36M-101.0% margin

Operating Income

-$54M-150.0% margin

Net Income

-$49M-137.0% margin

EPS (Diluted)

$-1.05

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$41M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$390M

Total Liabilities

$108M

Stockholders' Equity

$282M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$36M	$88M	-59.2%
Gross Profit	-$36M	$36M	-201.2%
Operating Income	-$54M	$23M	-337.6%
Net Income	-$49M	$24M	-307.1%